Waters Corp. has experienced several noteworthy developments, confirming the continued growth of the company, especially in the bio-tech supplies and solutions field. Stocks were upgraded to Outperform by Wolfe Research, with overall performance outpacing the Nasdaq. State Street Corp substantially increased its position in Waters with a significant number of share purchases, adding faith in the company's growth. Waters' potential merger with BD's Biosciences & Diagnostic Solutions Business is said to create a leader in life science and diagnostics. They've also observed significant growth in Q2 2025 with strong sales and elevated guidance. In an interesting development, Waters has also concluded a $17.5 billion deal to acquire Becton Dickinson Unit, a move that signals strategic positioning in the face of tariff pressures. Despite some perceived risks concerning the merger, analysts predict that Waters' stock will continue to perform well due to its strong financials and growth potential.
Waters Corp WAT News Analytics from Wed, 12 Feb 2025 08:00:00 GMT to Fri, 12 Dec 2025 12:23:00 GMT -
Rating 7
- Innovation 8
- Information 6
- Rumor -5
